Methylnaltrexone for opioid-induced constipation in advanced illness.

All previously published studies using different classes of renin– angiotensin–aldosterone system–blocking drugs have shown that the initial antiproteinuric effect is closely associated with beneficial long-term outcomes of kidney and cardiovascular disease, as reviewed in this report.